Intellihealth Named UCSF Rosenman Innovator for 2022

Intellihealth UCSF Rosenman Innovators

Institute Selects Intellihealth as 2022 UCSF Rosenman Innovator

“Through the annual Innovators program, Rosenman identifies promising companies, connects them to resources, and integrates them into its network of founders, mentors, investors, and industry leaders. The program is in its seventh year; to date, Rosenman Innovators have raised more than $480 million in capital. The ultimate goal of the program is to assist health technology entrepreneurs in advancing their solutions to market.”

Read more

Related News